
Understanding a gene’s role in inflammatory bowel disease
UC Riverside mouse study will identify mechanisms the gene PTPN2 uses to affect gut cells

How the coronavirus could be prevented from invading a host cell
UC Riverside-led study shows inhibiting two host cell proteases can accomplish the task

Scientists to study how lungs respond to worm infections
Research supported by five-year NIH grant may have relevance for COVID-19 patients

How does soap kill the coronavirus?
UC Riverside biomedical scientist Marcus Kaul explains

Doubling down on cancer-causing genes
NIH grant of $2.2 million could help researchers target two oncogenes, potentially leading to therapies for melanoma, lung cancer, and other tumors

Drug decreases gut leakiness associated with ulcerative colitis
UC Riverside-led study is the first to show how tofacitinib affects epithelial cells lining the gut

Space travel can make the gut leaky
UC Riverside-led study tested the effects of microgravity on intestinal epithelial cells

Not so quiet, please
UC Riverside mouse study finds early exposure to sounds can address hypersensitivity to noise associated with Fragile X Syndrome

Biomedical scientist to study how body’s cannabis-like molecules influence obesity
Research is supported by a five-year grant to UC Riverside from the National Institutes of Health

Curbing your enthusiasm for overeating
UC Riverside-led mouse study focuses on cannabis-like molecules that augment feeding behavior

UCR receives its first cannabis grant
School of Medicine’s Nicholas DiPatrizio will lead a team tasked with assessing the impact of long-term cannabis exposure on metabolic health and disease

A new approach to targeting cancer cells
UC Riverside researchers develop new drugs that target therapeutically relevant protein surfaces
Hope on the horizon for treating stroke
UC Riverside biomedical scientist’s decades-long work moves to clinical trials

Research offers superior therapeutic approach for MS
Multiple sclerosis is an autoimmune disease that affects more than 2.3 million people worldwide. This debilitating condition periodically shutters communication between the brain and other parts of the body, resulting in symptoms that range from numbness and tingling in the arms and legs to blindness and paralysis. While treatments are...